Switch to:

Arrowhead Pharmaceuticals Debt-to-Revenue

: 0.20 As of Jun. 2020
View and export this data going back to 1997. Start your Free Trial

Debt-to-Revenue measures a company's ability to pay off its debt.

Arrowhead Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2020 was $1.0 Mil. Arrowhead Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2020 was $20.4 Mil. Arrowhead Pharmaceuticals's annualized Revenue for the quarter that ended in Jun. 2020 was $109.5 Mil. Arrowhead Pharmaceuticals's annualized Debt-to-Revenue for the quarter that ended in Jun. 2020 was 0.20.


Arrowhead Pharmaceuticals Debt-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Arrowhead Pharmaceuticals Annual Data
Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
Debt-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.99 17.26 0.08 0.14 0.00

Arrowhead Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Debt-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.13 0.16 0.20

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Arrowhead Pharmaceuticals Debt-to-Revenue Distribution

* The bar in red indicates where Arrowhead Pharmaceuticals's Debt-to-Revenue falls into.



Arrowhead Pharmaceuticals Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Arrowhead Pharmaceuticals's Debt-to-Revenue for the fiscal year that ended in Sep. 2019 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 0) / 168.796
=0.00

Arrowhead Pharmaceuticals's annualized Debt-to-Revenue for the quarter that ended in Jun. 2020 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.012 + 20.36) / 109.504
=0.20

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jun. 2020) Revenue data.


Arrowhead Pharmaceuticals Debt-to-Revenue Related Terms


Arrowhead Pharmaceuticals Debt-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)